COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor (MACBETH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01896284
Recruitment Status : Completed
First Posted : July 11, 2013
Last Update Posted : November 23, 2018
TFS Trial Form Support
Information provided by (Responsible Party):
Barcelona Macula Foundation

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2014
Actual Study Completion Date : June 2015